ZTS
ZTS
NYSE · Pharmaceuticals

Zoetis Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$71.40
-1.62 (-2.22%)
As of Sep 20, 9:34 PM ET ·
Analyst Consensus
Hold
24
Analysts
High
Coverage
Buy 12 50%
Hold 12 50%
Sell 0 0%
Price Target
Analyst Price Target +193.9% upside
Low Target $137.04
Average Target $209.87
High Target $267.95
Current Price $71.40
Current
$71.40
Target
$209.87
$137.04 $209.87 avg $267.95
Scenario Analysis
Bear Case
$137.04
91.9%
Low target
Base Case
$209.87
+193.9%
Avg target
Bull Case
$267.95
+275.3%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$149.54
-52.3% from high
52-Week Low
$71.00
+0.6% from low
50-Day SMA
$124.55
-42.7% vs SMA
200-Day SMA
$142.48
-49.9% vs SMA
RSI (14)
62.1
Neutral
Target vs 52W High
$209.87
+40.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +15.4%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +10.9%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +8.4%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +22.6%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +176.7%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -37.9%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +193.9%